Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRC10B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | RBMY1J | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | PHKA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | DUSP10 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SDHD | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | UGGT2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | PRSS53 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | IQCC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | OTUD7B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | EML5 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |